Impact of discrepancies between the Abbott RealTime and Cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes

Journal of Clinical Microbiology

Volumn 47, Issue 5, 2009, Pages 1543-1545

  Wirden, M ^a,b   Tubiana, R ^a,b   Marguet, F ^a   Leroy, I ^a   Simon, A ^a   Bonmarchand, M ^a   Ait Arkoub, Z ^a   Murphy, R ^a   Marcelin, A G ^a,b   Katlama, C ^a,b   Calvez, V ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; ASSAY; BLOOD SAMPLING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; PRIORITY JOURNAL; TAQMAN ASSAY; VIRUS LOAD;

HIV-1; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; REAGENT KITS, DIAGNOSTIC; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 66149147547     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02134-08     Document Type: Article

References (10)

1. Braun, P., R. Ehret, F. Wiesmann, F. Zabbai, M. Knickmann, R. Kuhn, S. Thamm, G. Warnat, and H. Knechten. 2007. Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine. Clin. Chem. Lab. Med. 45:93-99. (Pubitemid 46155568)
2. Damond, F., B. Roquebert, A. Benard, G. Collin, M. Miceli, P. Yeni, F. Brun- Vezinet, and D. Descamps. 2007. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays. J. Clin. Microbiol. 45:3436-3438. (Pubitemid 47585682)
3. Descamps, D., M. L. Chaix, P. Andre, V. Brodard, J. Cottalorda, C. Deveau, M. Harzic, D. Ingrand, J. Izopet, E. Kohli, B. Masquelier, S. Mouajjah, P. Palmer, I. Pellegrin, J. C. Plantier, C. Poggi, S. Rogez, A. Ruffault, V. Schneider, A. Signori-Schmuck, C. Tamalet, M. Wirden, C. Rouzioux, F. Brun-Vezinet, L. Meyer, and D. Costagliola. 2005. French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002. J. Acquir. Immune Defic. Syndr. 38:545-552. (Pubitemid 40524476)
4. Gueudin, M., J. C. Plantier, V. Lemee, M. P. Schmitt, L. Chartier, T. Bourlet, A. Ruffault, F. Damond, M. Vray, and F. Simon. 2007. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J. Acquir. Immune Defic. Syndr. 44:500-505. (Pubitemid 46594892)
5. Hemelaar, J., E. Gouws, P. D. Ghys, and S. Osmanov. 2006. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 20:W13-W23.
6. Holguin, A., M. Lopez, M. Molinero, and V. Soriano. 2008. Performance of three commercial viral load assays, Versant human immunodeficiency virus type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, testing HIV-1 non-B subtypes and recombinant variants. J. Clin. Microbiol. 46:2918-2923.
7. Panel on Antiretroviral Guidelines for Adults and Adolescents. 3 November 2008, posting date. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services, Washington, DC. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL. pdf.
8. Saag, M. S., M. Holodniy, D. R. Kuritzkes, W. A. O'Brien, R. Coombs, M. E. Poscher, D. M. Jacobsen, G. M. Shaw, D. D. Richman, and P. A. Volberding. 1996. HIV viral load markers in clinical practice. Nat. Med. 2:625-629. (Pubitemid 26191942)
9. Wensing, A. M., D. A. van de Vijver, G. Angarano, B. Asjo, C. Balotta, E. Boeri, R. Camacho, M. L. Chaix, D. Costagliola, A. De Luca, I. Derdelinckx, Z. Grossman, O. Hamouda, A. Hatzakis, R. Hemmer, A. Hoepelman, A. Horban, K. Korn, C. Kucherer, T. Leitner, C. Loveday, E. MacRae, I. Maljkovic, C. de Mendoza, L. Meyer, C. Nielsen, E. L. Op de Coul, V. Ormaasen, D. Paraskevis, L. Perrin, E. Puchhammer-Stockl, L. Ruiz, M. Salminen, J. C. Schmit, F. Schneider, R. Schuurman, V. Soriano, G. Stanczak, M. Stanojevic, A. M. Vandamme, K. Van Laethem, M. Violin, K. Wilbe, S. Yerly, M. Zazzi, and C. A. Boucher. 2005. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management. J. Infect. Dis. 192:958-966.
10. Yeni, P. 2008. Rapport 2008: prise en charge médicale de personnes infectées par le VIH. Flammarion, Paris, France.